Clinical Trial Update: Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for preventing migraines in children aged 6 to 11 using Qudexy XR (topiramate extended-release); the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qudexy XR (topiramate extended-release)

Snippet

Sponsor: Upsher-Smith Laboratories | Conditions: Migraine Disorders | Phase 4 | Status: RECRUITING